Page 356 - Motor Disorders Third Edition
P. 356

338 / chapter 17                                                           	23.	 Thomas NH, Robinson L, Evans A, et al. The floppy infant: a
REFERENCES                                                                         new manifestation of nonaccidental injury. Pediatr Neurosurg
                                                                                   1995; 23:188–191.
	 1. 	 Sauerland EK, Knauss T, Nakamura Y, et al. Inhibition of
        monosynaptic and polysynaptic reflexes and muscle tone by          	24.	 al-Qudah AA, Shahar E, Logan WJ, et al. Neonatal Guillain-
        electrical stimulation of the cerebral cortex. Exp Neurol 1967;            Barré syndrome. Pediatr Neurol 1988; 4:255–256.
        17:159–171.
                                                                           	25.	 NINCDS ad hoc Guillain-Barré syndrome committee. Criteria
	 2. 	 Sarnat HB. Do the corticospinal and corticobulbar tracts                    for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978;
        mediate functions in the human newborn? Can J Neurol Sci                   3:565–566.
        1989; 16:157–160.
                                                                           	26.	 Cornblath DR. Electrophysiology in Guillain-Barré syndrome.
	 3.	 Lesny IA. Follow-up study of hypotonic forms of cerebral                     Ann Neurol 1990; 27[Suppl]:S17–20.
        palsy. Brain Dev 1979; 1:87–90.
                                                                           	27.	 Dworkin MS, Shoemaker PC, Anderson DE. Tick paralysis: 33
	 4.	 Clancy RR, Sladky JY, Rorke LB. Hypoxic-ischemic spinal                      human cases in Washington State, 1946-1996. Clin Infectious
        cord injury following perinatal asphyxia. Ann Neurol 1989;                 Dis 1999; 19:1435–1439.
        25:185–189.
                                                                           	28.	 Aubourg P, Scotto J, Rocchiccioli F, et al. Neonatal adrenoleu-
	 5.	 Rousseau S, Metral S, Lacroix C, et al. Anterior spinal artery               kodystrophy. J Neurol Neurosurg Psychiatry 1986; 49:77–86.
        syndrome mimicking infantile spinal muscular atrophy. Am J
        Perinatol 1993; 10:316–318.                                        	29.	 Ozmen M, Caliskan M, Goebel HH, et al. Infantile neuroax-
                                                                                   onal dystrophy: diagnosis by skin biopsy. Brain Dev 1991;
	 6.	 Reynolds JF, Daniel A, Kelly TE. Isochromosome 12p mosa-                     13:256–259.
        icism (Pallister mosaic aneuploidy or Pallister-Killian syn-
        drome): report of 11 cases. Am J Med Genet 1987; 27:257–274.       	30.	 Kimura S. Terminal axon pathology in infantile neuroaxonal
                                                                                   dystrophy. Pediatr Neurol 1991;7:116–120.
	 7.	 Gorski JL, Cox BA, Kyine M, et al. Terminal deletion of the
        long arm of chromosome 2 in a mildly dysmorphic hypotonic          	31.	 Infant botulism. New York City, 2001–2002. MMWR Morb
        infant with karyotype 46,XY,del(2)(q37). Am J Med Genet                    Mort Wkly Rep 2003; 52:21–24.
        1989; 32:350–352.
                                                                           	32.	 Hurst DL, Marsh WW. Early severe infantile botulism. J Pedi-
	 8.	 Feldman GL, Weiss L, Phelan MC, et al. Inverted duplication                  atr 1993;122:909–911.
        of 8p: ten new patients and review of the literature. Am J Med
        Genet 1993; 47:482–486.                                            	33.	 Patural P, Goffaux P, Paricio C, et al. Infant botulism intoxi-
                                                                                   cation and autonomic nervous system dysfunction. Anaerobe
	 9.	 Nelson J, Flaherty M, Grattan-Smith P. Gillespie syndrome: a                 2009; 15:197–200.
        report of two further cases. Am J Med Genet 1997; 71:134–138.
                                                                           	34.	 Cornblath DR, Sladky JT, Sumner AJ. Clinical electrophysiol-
	10.	 Kronenberg JR, Chen XN, Schipper R, et al. Down syndrome                     ogy of infantile botulism. Muscle Nerve 1983; 6:448–452.
        phenotypes: the consequences of chromosomal imbalance.
        Proc Natl Acad Sci USA 1994; 91:4997–5001.                         	35.	 Smith GE, Hinde F, Westmoreland D, et al. Infantile botulism.
                                                                                   Arch Dis Child 1989; 64:871–872.
	11.	 Gosset P, Ghezala GA, Korn P, et al. A new inward rectifier
        potassium channel gene (KCNJ15) localized on chromosome            	36.	 Engel AG. Congenital myasthenic syndromes. Handb Clin
        21 in the Down syndrome chromosome region 1 (DCR1).                        Neurol 2008; 91:285–331.
        Genomics 1997; 44:237–241.
                                                                           	37.	 Goebel HH. Congenital myopathies. Acta Paediatr Jpn 1991;
	12.	 Virtanen M. Manifestations of congenital hypothyroidism                      33:247–255.
        during the 1st week of life. Eur J Pediatr 1988; 147:270–274.
                                                                           	38.	 Toda T, Segawa M, Nomura Y, et al. Localization of a gene for
	13.	 Roberts HE, Moore CA, Fernhoff PM, et al. Population study                   Fukuyama type congenital muscular dystrophy to chromosome
        of congenital hypothyroidism and associated birth defects,                 9q31-33. Nat Genet 1993; 5;283–286.
        Atlanta, 1979–1992. Am J Med Genet 1997; 71:29–32.
                                                                           	39.	 Kobayashi K, Nakahori Y, Miyake M, et al. An ancient retrotrans-
	14.	 Greenberg F, Elder FF, Ledbetter DH. Neonatal diagnosis of                   posal insertion causes Fukuyama-type congenital muscular dys-
        Prader-Willi syndrome and its implications. Am J Med Genet                 trophy. Nature 1998; 394:388–392.
        1987; 28:845–856.
                                                                           	40.	 Tome FMS, Evangelista T, Leclerc A, et al. Congenital muscu-
	 15.	 Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome:               lar dystrophy with merosin deficiency. CR Acad Sci III 1994;
        consensus diagnostic criteria. Pediatrics 1993; 91:398–402.                317:351–357.

	16.	 Gillessen-Kaesbach G, Gross S, Kaya-Westerloh S, et al. DNA          	 41.	 Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the
        methylation based testing of 450 patients suspected of having              laminin a2-chain gene (LAMA2) cause merosin-deficient con-
        Prader-Willi syndrome. J Med Genet 1995; 32:88–92.                         genital muscular dystrophy. Nat Genet 1995; 11:216–218.

	17.	 Wolf B, Heard GS, Weissbecker KA, et al. Biotinidase defi-           	42.	 Vervoort VS, Holden KR, Ukadike KC, et al. POMGnT1 gene
        ciency: initial clinical features and rapid diagnosis. Ann Neurol          alterations in a family with neurological abnormalities. Ann Neu-
        1985; 18:614–617.                                                          rol 2004; 56:143–148.

	18.	 Collins JE, Nicholson NS, Dalton N, et al. Biotinidase defi-         	 43.	 Tsao CY, Boesel CP, Wright FS. A hypotonic infant with complete
        ciency: early neurological presentation. Dev Med Child Neurol              deficiencies of acid maltase and debrancher enzyme. J Child Neu-
        1994; 36:268–270.                                                          rol 1994; 9:90–91.

	19.	 De Vivo DC, Johnston MV. Forward to supplement on pediatric          	44.	 Van den Hout HMP, Hp W, van Diggelen OP, et al. The natural
        neurotransmitter diseases. Ann Neurol 2003; 54 Suppl 6:S1–2.               course of infantile Pompe’s disease: 20 original cases compared
                                                                                   with 133 cases from the literature. Pediatrics 2003; 112:332–340.
	20.	 Doummar D, Clot F, Vidailhet M, et al. Infantile hypokinetic-
        hypotonic syndrome due to two novel mutations of the tyro-         	45.	 Berkner P, Kastner T, Skolnick L. Chronic ipecac poisoning in
        sine hydroxylase gene. Mov Disord 2009; 24: 943–945.                       infancy: a case report. Pediatrics 1988; 82:384–386.

	21.	 Pons, R, Ford B, Chiriboga CA, et al. Aromatic L-amino acid          	46.	 Sofer S, Tal A, Shahak E. Carbamate and organophosphate poi-
        decarboxylase deficiency: clinical features, treatment, and                soning in early childhood. Pediatr Emerg Care 1989; 5:222–225.
        prognosis. Neurology 2004; 62:1058–1065.
                                                                           	47.	 Woolf AD, Wynshaw-Boris A, Rinaldo P, Levy HL. Intentional
	22.	 Kuwata T, Matsubara S, Ohkusa T, et al. Decreased fetal                      infantile ethylene glycol poisoning presenting as an inherited
        movement prompts investigation of prenatal/neonatal nema-                  metabolic disorder. J Pediatr 1992; 120:421–424.
        line myopathy: the possible merit of fetal movement count.
        J Obstet Gynaecol Res 2011; 37:921–925.                            	48.	 Mason TBS, De Vivo DC. The floppy infant syndrome. In: Row-
                                                                                   land LP, ed. Merritt’s textbook of neurology, 10th Ed. Baltimore:
                                                                                   Williams & Wilkins, 2000.
   351   352   353   354   355   356   357   358   359   360   361